Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Clinical trial NCT02947386 · COMPLETED

Trial details

NCT number: NCT02947386
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

EGFR Gene Mutation Recurrent Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer

Start date: 2017-06-29
Primary completion: 2021-04-15
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.